INFUSOR
Report
- Report Number
- 1416980-2020-05191
- Event Type
- Malfunction
- Date Received
- August 26, 2020
- Date of Event
- July 30, 2020
- Report Date
- September 24, 2020
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Product Code
- MEB
- UDI-DI
- 00085412579399
- PMA / PMN Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- EZ
- Reporter Occupation
- PHARMACIST
Narratives
ADDITIONAL INFORMATION WAS ADDED TO D10, H3, H4 AND H6: H4: THE LOT WAS MANUFACTURED FROM DECEMBER 16, 2020 - DECEMBER 17, 2020. H10: THE ACTUAL DEVICE WAS RECEIVED FOR EVALUATION. A VISUAL INSPECTION WAS PERFORMED USING THE NAKED EYE WHICH DID NOT IDENTIFY ANY ABNORMALITIES THAT COULD HAVE CONTRIBUTED TO THE REPORTED CONDITION. AFTER THE LUER CAP WAS REMOVED, EVIDENCE OF CONTINUOUS FLOW WAS OBSERVED AT THE DISTAL LUER. A FUNCTIONAL FLOW RATE TEST WAS PERFORMED AND FOUND TO BE WITHIN THE PRODUCT SPECIFICATION RANGE. THE DEVICE WAS FOUND TO BE CONFORMING PRODUCT. THE REPORTED CONDITION WAS NOT VERIFIED. A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
(B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
IT WAS REPORTED THAT THERE WAS NO FLOW OF MEDICATION THROUGH A LARGE VOLUME INFUSOR. AFTER 48 HOURS FROM ADMINISTRATION, IT WAS OBSERVED THAT THE INFUSOR WAS FULL AND HAD NOT DELIVERED ANY MEDICATION TO THE PATIENT. THE DEVICE HAD BEEN FILLED WITH 5-FLUOROURACIL EBEWE. TO RESOLVE THE ISSUE, THE UNIT WAS REPLACED WITH A NEW ONE AND TREATMENT WAS RESUMED. THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 921743 | INFUSOR | PUMP, INFUSION, ELASTOMERIC | MEB | BAXTER HEALTHCARE CORPORATION | NA | 19N023 | 00085412579399 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 5-FLUOROURACIL EBEWE.| 5-FLUOROURACIL EBEWE |